• Ziprasidone Augmentation of Escitalopram in Anxious Depressi

  2026-06-03

  This article examines a post-hoc analysis of a randomized trial investigating whether ziprasidone augmentation enhances escitalopram's efficacy in patients with anxious depression. The findings offer nuanced guidance for antidepressant research, revealing no significant additional anxiolytic benefit from ziprasidone co-administration.

• Hexetidine (NSC-17764): Applied Antimicrobial Workflows for

  2026-06-03

  Hexetidine (NSC-17764) empowers researchers with a flexible, broad-spectrum antimicrobial solution for oral biofilm inhibition, dental plaque reduction, and clinical gingivitis models. This article distills protocol parameters, comparative insights, and troubleshooting tips to maximize reproducibility and impact in oral infection studies.

• Berberrubine Chloride: Precision Modulation of Urate Pathway

  2026-06-02

  Explore the advanced mechanisms of Berberrubine chloride, a potent 9-hydroxy-10-methoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium chloride, in hyperuricemia and cancer research. This article uniquely highlights its urate transporter modulation and translational impact, bridging metabolic and oncology workflows.

• Calcitriol (SKU B2141): Data-Driven Solutions for Cell Assay

  2026-06-02

  This article addresses laboratory challenges in cell viability and signaling assays, demonstrating how Calcitriol (SKU B2141) from APExBIO enables reproducible, quantitative workflows. Scenario-based insights clarify experimental design, protocol optimization, and product selection, offering actionable guidance for biomedical researchers.

• Quinolone–Coumarin Hybrids Show Promise Against Toxoplasma g

  2026-06-01

  This study introduces novel quinolone–coumarin hybrids derived from fluoroquinolones and novobiocin, evaluating their in vitro anti-parasitic effects on Toxoplasma gondii. Key hybrids demonstrated notable selectivity and efficacy, suggesting a new direction for anti-Toxoplasma agent development with minimized host cell toxicity.

• Cinoxacin (BA1045): In-Depth MIC Protocols and Resistance In

  2026-06-01

  Explore Cinoxacin, a potent quinolone antibiotic, through a protocol-focused lens. This article delivers advanced guidance on MIC assay design, resistance modeling, and practical pharmacokinetic considerations that go beyond standard UTI research applications.

• Decitabine in Translational Epigenetics: Mechanisms and Mome

  2026-05-31

  Explore how Decitabine (5-Aza-2'-deoxycytidine) is redefining translational research at the intersection of cancer epigenetics, immunomodulation, and clinical innovation. This article blends mechanistic depth with practical strategy for investigators seeking to leverage advanced DNA methylation inhibition in both hematopoietic and solid tumor contexts, while highlighting avenues for immune rebalancing and future-ready research workflows.

• Lactoferrin Potentiates Novobiocin Activity Against E. coli

  2026-05-30

  This study demonstrates that bovine lactoferrin significantly enhances the antibacterial activity of Novobiocin against Escherichia coli, including both laboratory and bovine mastitis isolates. The findings highlight a promising strategy for overcoming Gram-negative permeability barriers and provide mechanistic insight for the development of combination antimicrobial therapies.

• Berberrubine Chloride: Mechanistic Leverage for Translationa

  2026-05-29

  Explore how Berberrubine chloride, a selective IMPDH2 and TrxR inhibitor, is redefining translational and preclinical models in cancer and metabolic disease research. This thought-leadership article blends deep mechanistic insight with pragmatic strategy, highlighting protocol optimization, competitive differentiation, and the translational promise illuminated by recent literature.

• GSK3 Inhibition as a Host-Directed Approach for Tuberculosis

  2026-05-29

  The referenced iScience study demonstrates that inhibition of glycogen synthase kinase 3 (GSK3) in human macrophages effectively restricts intracellular Mycobacterium tuberculosis (Mtb) growth. By leveraging kinase inhibitors and genetic knockdown strategies, the work highlights a promising host-directed therapy (HDT) pathway that could complement or offer alternatives to traditional antibiotics in the fight against multi-drug resistant tuberculosis (MDR-TB).

• Salmonella Haem Biosynthesis Drives Macrophage Phagocytosis

  2026-05-28

  A recent study reveals that Salmonella Typhimurium uses a methyltransferase to upregulate haem biosynthesis, thereby inhibiting macrophage phagocytosis and promoting infection in mice. This mechanism clarifies the significance of pathogen-derived haem in immune evasion and provides new directions for dissecting host-pathogen interactions in infection biology.

• Scalable EPSC-MSC EV Production for Pulmonary Fibrosis Thera

  2026-05-28

  This study presents a robust, bioreactor-based platform for scalable production of extracellular vesicles (EVs) from extended pluripotent stem cell-derived mesenchymal stem cells (EPSC-iMSCs). The findings address major limitations in current EV biomanufacturing, delivering consistent therapeutic efficacy in a pulmonary fibrosis model and opening new avenues for standardized regenerative medicine applications.

• Recombinant Human IL-15: Enhancing Immune Cell Assays

  2026-05-27

  Unlock robust T and NK cell expansion with APExBIO’s Recombinant Human IL-15 (E.coli, Tag Free, Lyophilized). This guide delivers workflow enhancements, troubleshooting strategies, and real-world assay innovations for immune response modulation in translational research.

• Homoharringtonine: Precision Cytotoxic Alkaloid for Next-Gen

  2026-05-27

  Explore how Homoharringtonine, a potent cytotoxic alkaloid, redefines assay rigor in leukemia and SARS-CoV-2 antiviral research. This article uniquely dissects advanced mechanistic insights and protocol optimization strategies.

• Homoharringtonine: Applied Workflows in Leukemia and Antivir

  2026-05-26

  Homoharringtonine’s dual efficacy as a cytotoxic alkaloid offers precise control for both leukemia research and emerging antiviral workflows. This guide details experimental setups, troubleshooting, and translational advancements, helping labs harness its full potential for protein synthesis inhibition and rapid viral clearance.

453 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page